Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada | Zendy

Kyle A. Thompson | Zendy; Gabriel Blank | Zendy; Junine Toy | Zendy; David Moore | Zendy; Nathan J. Lachowsky | Zendy; Nicanor Bacani | Zendy; Wei Zhang | Zendy; Paul Sereda | Zendy; Viviane D. Lima | Zendy; Rolando Barrios | Zendy; Julio Montaner | Zendy; Mark Hull | Zendy

Open Access

Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada

Author(s) -

Kyle A. Thompson,

Gabriel Blank,

Junine Toy,

David Moore,

Nathan J. Lachowsky,

Nicanor Bacani,

Wei Zhang,

Paul Sereda,

Viviane D. Lima,

Rolando Barrios,

Julio Montaner,

Mark Hull

Publication year - 2021

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofab492

Subject(s) - medicine , human immunodeficiency virus (hiv) , chronic hepatitis , hepatitis b virus , family medicine , population , hepatitis b , virology , virus , environmental health

Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research